News

Comcast NBCUniversal LIFT Labs Accelerator, Powered By Techstars, Celebrates Five Years of Startup Partnerships as Applications Open for The 2022 Class

Comcast today announced it is now accepting applications from global startups in connectivity, media, and entertainment for the fifth class of the Comcast NBCUniversal LIFT Labs Accelerator,

BusinessWire_EN

0

Comcast NBCUniversal LIFT Labs Accelerator, Powered By Techstars, Celebrates Five Years of Startup Partnerships as Applications Open for The 2022 Class

Comcast today announced it is now accepting applications from global startups in connectivity, media, and entertainment for the fifth class of the Comcast NBCUniversal LIFT Labs Accelerator,

BusinessWire_EN

0

Comcast NBCUniversal LIFT Labs Accelerator, Powered By Techstars, Celebrates Five Years of Startup Partnerships as Applications Open for The 2022 Class

Comcast today announced it is now accepting applications from global startups in connectivity, media, and entertainment for the fifth class of the Comcast NBCUniversal LIFT Labs Accelerator,

BusinessWire_EN

0

Kohl's Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

Kohl’s Corporation (NYSE:KSS) today reported results for the quarter and year ended January 29, 2022.

Three Months

Twelve Months

($ in millions, except per share data)

2021

BusinessWire_EN

0

CI Global Asset Management Builds on Thematic ETF Lineup with Launch of CI Bio-Revolution and CI Digital Security ETFs

CI Global Asset Management (“CI GAM”) today announced the launch of two ETFs providing exposure to rapidly growing sectors at the forefront of innovation and technological development – CI

BusinessWire_EN

0

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

Pfizer Inc. (NYSE:PFE) today announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating its Clostridioides difficile (C. difficile)

BusinessWire_EN

0

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

Pfizer Inc. (NYSE:PFE) today announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating its Clostridioides difficile (C. difficile)

BusinessWire_EN

0

NICE Actimize Receives 2022 “Best Technology Management Team North America” Award from Global Banking and Finance Review

NICE Actimize, a NICE (NASDAQ: NICE) business, today announced that Global Banking and Finance Review, a financial media platform with over three million readers worldwide, has awarded the company

BusinessWire_EN

0

Chevron Executing Plans to Deliver Higher Returns and Lower Carbon

At its annual investor meeting today, Chevron Corporation (NYSE: CVX) reported on its progress to deliver higher returns and advance a lower carbon future.

“Chevron’s executing a straightforward

BusinessWire_EN

0

Chevron Executing Plans to Deliver Higher Returns and Lower Carbon

At its annual investor meeting today, Chevron Corporation (NYSE: CVX) reported on its progress to deliver higher returns and advance a lower carbon future.

“Chevron’s executing a straightforward

BusinessWire_EN

0

Interactive Brokers führt Traders' Insight Radio ein

Interactive Brokers (Nasdaq: IBKR), ein automatisierter, globaler elektronischer Broker, gab heute den Start von Traders’ Insight Radio bekannt. Diese neue Podcast-Serie beinhaltet Interviews mit